(Q41509247)

1 October 2017

1 reference

title

Species differences in the role of excitatory amino acids in experimental parkinsonism (English)

1 reference

1 October 2017

1 reference

4

1 reference

1 October 2017

1

F Fornai

1 reference

1 October 2017

3

R Maggio

1 reference

1 October 2017

Vaglini F

2

1 reference

1 October 2017

Corsini GU

series ordinal

5

1 reference

1 October 2017

language of work or name

1 reference

1 July 1997

1 reference

Neuroscience & Biobehavioral Reviews

1 October 2017

published in

1 reference

1 October 2017

volume

21

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

401-415

1 reference

Oxygen free radicals regulate NMDA receptor function via a redox modulatory site

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

A 3,4-dihydroxyphenylalanine oxidation product is a non-N-methyl-D-aspartate glutamatergic agonist in rat cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Glutathione prevents 2,4,5-trihydroxyphenylalanine excitotoxicity by maintaining it in a reduced, non-active form.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Alternative excitotoxic hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Differing neurotoxic potencies of methamphetamine, mazindol, and cocaine in mesencephalic cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Structure-activity relations of excitatory amino acids on frog and rat spinal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Dextromethorphan and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

NMDA antagonists partially protect against MPTP induced neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

2,4,5-Trihydroxyphenylalanine (6-hydroxy-DOPA) displaces [3H]AMPA binding in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

MPP+Enhances Potassium-Evoked Striatal Dopamine Release through a ?-ConOtoxin-Insensitive, Tetrodotoxin- and Nimodipine- Sensitive Calcium-Dependent Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Cell Damage Associated with Changing the Medium of Mesencephalic Cultures in Serum-Free Medium Is Mediated via N-Methyl-D-Aspartate Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Glutamate: A Neurotransmitter in Mammalian Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Substantia nigra lesion protects against ischemic damage in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Ischemic CA-1 pyramidal cell loss is prevented by preischemic colchicine destruction of dentate gyrus granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Mechanisms involved in irreversible anoxic damage to thein vitrorat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

NMDA-dependent superoxide production and neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The toxic effect of sodium L-glutamate on the inner layers of the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The release and uptake of excitatory amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Excitotoxic amino acids and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Glutamate neurotoxicity and Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Lesions to Schaffer collaterals prevent ischemic death of CA1 pyramidal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The role of excitatory amino acids in experimental models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

N-methyl-D-aspartate increases the excitability of nigrostriatal dopamine terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Effects of MPTP on the fine structure of neurons in substantia nigra of dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Synaptic activity mediates death of hypoxic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Mechanisms of action of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Cell damage in the brain: a speculative synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

"Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Role of excitatory amino-acids in diethyldithiocarbamate-induced cell death in mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900042-5

7 January 2021

10.1016/S0149-7634(96)00042-5

Identifiers

DOI

1 reference

1 October 2017

1 reference